Gerdau S.A. Common Stock vs Roivant Sciences Ltd. Common Shares — how do they compare? Gerdau S.A. Common Stock trades at $5.06 (market cap $9.16B), while Roivant Sciences Ltd. Common Shares trades at $34.76 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 2.7× Gerdau S.A. Common Stock's market cap, and Gerdau S.A. Common Stock pays a 3.67% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gerdau S.A. Common Stock for 0 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| GGB | ROIV | |
|---|---|---|
Market Cap | $9.16B | $24.72B |
Volume | 16,238,936 | 6,279,442 |
Sector | Basic Materials | Health |
52-Week High | $5.17 | $41.81 |
52-Week Low | $3.15 | $16.04 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $11.10B | $20.99B |
Dividend Yield | 3.67% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Gerdau is a steel producer with operations across the Americas. It makes long steel, specialty steel, and other products for construction and industrial markets.
Read more on GGB →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →